Mae Roche bellach wedi cytuno i'r un telerau mynediad masnachol i GIG Cymru â GIG Lloegr. Golyga hyn y bydd modd i gleifion o Gymru sydd â rhai mathau o ganser datblygedig y fron fanteisio ar y driniaeth.
Roche has now agreed with NHS Wales the same commercial access agreement as NHS England. This means that Welsh patients with certain types of advanced breast cancer will be able to benefit from the treatment.